Evaluation of Resection Techniques for Pancreatic Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMethodist Health System
About this trial
The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint.
The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
Patients 18 years old or older
Disqualifiers
Patients that have not undergone pancreatic resection surgeries
Patients under 18 years of age
Trial population
pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
Trial design
Design model
Other
Time perspective
Retrospective
Treatments tested in this trial
Resection techniques for pancreatic and liver tumors
Procedure/Surgeryto compare open versus minimally invasive pancreatic resection techniques and analyze the different outcome variables from the clinical standpoint
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Patient Survival
It will be calculated in days.Minimally invasive techniques are being adopted for complex pancreatic and liver surgery and there is a need to understand if these techniques are advantageous to the patient, if the cost is justified and if the risks are acceptable when compared to the gold standard open surgery.
Time frame
through study completion, an average of 1 year2
Length of stay
It will be calculated in days. The days stayed in hospital post-procedure.
Time frame
Up to 1 year3
Complication rates
Patient may visit physician or hospital for any symptoms or may need hospitalizations.
Time frame
through study completion, an average of 1 year4
Operative time
The time required for the procedure.
Time frame
up to 10 hoursSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov